[1] |
Beyer G,Habtezion A,Werner J,et al. Chronic pancreatitis[J].Lancet,2020,396(10249):499-512.
|
[2] |
Vege SS,Chari ST. Chronic Pancreatitis[J]. N Engl J Med,2022,386(9):869-878.
|
[3] |
Thierens N,Verdonk RC,Löhr JM,et al. Chronic pancreatitis[J].Lancet,2025,404(10471):2605-2618.
|
[4] |
Gandhi S,de la Fuente J,Murad MH,et al. Chronic Pancreatitis Is a Risk Factor for Pancreatic Cancer, and Incidence Increases With Duration of Disease:A Systematic Review and Meta-analysis[J].Clin Transl Gastroenterol,2022,13(3):e00463.
|
[5] |
Singh VK,Yadav D,Garg PK. Diagnosis and Management of Chronic Pancreatitis: A Review[J]. JAMA,2019,322(24):2422-2434.
|
[6] |
Liu L,Zhang T,Sui Y,et al. Gut microbiota affects pancreatic fibrotic progression through immune modulation in chronic pancreatitis[J].Microb Pathog,2023,177:106035.
|
[7] |
Wu N,Xu XF,Xin JQ,et al.The effects of nuclear factor-kappa B in pancreatic stellate cells on inflammation and fibrosis of chronic pancreatitis[J].J Cell Mol Med,2021,25(4):2213-2227.
|
[8] |
Jiao Y,Wu L,Huntington ND,et al. Crosstalk Between Gut Microbiota and Innate Immunity and Its Implication in Autoimmune Diseases[J].Front Immunol,2020,11:282.
|
[9] |
Hong J,Fu Y,Chen X,et al. Gut microbiome changes associated with chronic pancreatitis and pancreatic cancer: a systematic review and meta-analysis[J]. Int J Surg,2024,110(9):5781-5794.
|
[10] |
Pan LL,Li BB,Pan XH,et al. Gut microbiota in pancreatic diseases: possible new therapeutic strategies[J].Acta Pharmacol Sin,2021,42(7):1027-1039.
|
[11] |
Tao J,Cheema H,Kesh K, et al. Chronic pancreatitis in a caerulein-induced mouse model is associated with an altered gut microbiome[J]. Pancreatology,2022,22(1):30-42.
|
[12] |
Efremova I,Maslennikov R,Poluektova E,et al. Epidemiology of small intestinal bacterial overgrowth[J]. World J Gastroenterol,2023,29(22):3400-3421.
|
[13] |
Yang X,Xu H,Liang X,et al. Exploring the casual association between gut microbiome,circulating inflammatory cytokines and chronic pancreatitis: A Mendelian randomization analysis[J].Medicine (Baltimore). 2024,103(18):e37959.
|
[14] |
Gardner TB, Adler DG, Forsmark CE, et al. ACG Clinical Guideline: Chronic Pancreatitis[J]. Am J Gastroenterol,2020,115(3):322-339.
|
[15] |
Frost F,Weiss FU,Sendler M,et al. The Gut Microbiome in Patients With Chronic Pancreatitis Is Characterized by Significant Dysbiosis and Overgrowth by Opportunistic Pathogens[J]. Clin Transl Gastroenterol,2020,11(9):e00232.
|
[16] |
Brubaker L, Luu S, Hoffman K, et al. Microbiome changes associated with acute and chronic pancreatitis: A systematic review[J].Pancreatology,2021,21(1):1-14.
|
[17] |
van Loo G,Bertrand MJM.Death by TNF:a road to inflammation[J]. Nat Rev Immunol,2023,23(5):289-303.
|
[18] |
Lütt F, Ehlers L,Nizze H, et al. Different characteristics of chronic dibutyltin dichloride-induced pancreatitis and cholangitis in mouse and rat[J]. Hepatobiliary Pancreat Dis Int,2020,19(2):169-174.
|
[19] |
Zhang D,Li W,Wang M,et al. Methods of a New Chronic Pancreatitis and Spontaneous Pancreatic Cancer Mouse Model Using Retrograde Pancreatic Duct Injection of Dibutyltin Dichloride[J].Front Oncol,2022,12:947133.
|